Popular Trials
Stem Cell Therapy
Stem Cell Therapy for Parkinson's Disease
This trial is testing whether special cells from human fat tissue can help treat Parkinson's disease. The study involves patients with Parkinson's who will receive these cells. The goal is to see if these cells can repair or protect brain cells and improve symptoms. These cells have shown promise in animal models for treating Parkinson's disease.
Stem Cell Therapy
Neonatal Mesenchymal Cells for Dilated Cardiomyopathy
This trial aims to test if using special cells from newborns can help improve heart function in patients with Dilated Cardiomyopathy. The study is looking to see if these cells are safe and effective
Allograft
VIA Disc NP for Degenerative Disc Disease
This trial tests VIA Disc NP, a tissue injection for repairing damaged spine discs, in adults whose condition hasn't improved with usual treatments. The injection aims to support and heal the damaged discs, potentially reducing pain and improving function.
Popular Filters
Trials for Chronic Pain Patients
Procedure
SCS vs Conventional Management for Chronic Pain
This trial will compare the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities to Conventional Medical Management (CMM) in patients with chronic low back and/or leg pain who have not undergone spinal surgery.
Trials With No Placebo
Mesenchymal Stromal Cells
MSC Therapy for Asthma
This trial is testing the safety of using special stem cells to treat children and young adults with severe asthma that doesn't improve with regular treatments. The stem cells are given through an IV and may help reduce inflammation in the airways. The study aims to find out if this new treatment is safe and effective.
Procedure
SCS vs Conventional Management for Chronic Pain
This trial will compare the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities to Conventional Medical Management (CMM) in patients with chronic low back and/or leg pain who have not undergone spinal surgery.
Mesenchymal Stem Cells
AdMSCs for Osteoarthritis
This trial involves testing a treatment for osteoarthritis in 300 patients with affected knees, hips, and shoulders. The study will measure symptoms like pain and mobility to evaluate the treatment's effectiveness. The goal is to see if the new treatment can improve daily life and joint function for these patients.
View More Related Trials
Frequently Asked Questions
Introduction to scs
What are the top hospitals conducting scs research?
In the realm of cutting-edge clinical trials, several hospitals are making significant strides in the field of Stem Cell Research (SCR). One such institution is Hope Biosciences Stem Cell Research Foundation located in Sugar Land. With three ongoing SCR trials, this foundation is dedicated to exploring the potential of stem cells for various medical applications. While they have yet to conduct any previous SCR trials, their commitment to advancing research in this field holds great promise.
Another noteworthy hospital contributing to SCR research is PCPMG Clinical Research Unit, LLC situated in Greenville. They currently have two active SCR trials underway and like the previous foundation mentioned, have not conducted any prior studies on SCR treatments. However, their involvement shows a growing interest within the medical community towards unlocking the therapeutic potential of stem cells.
Moving on to Goodman Campbell Brain and Spine based in Carmel; they also boast two active clinical trials focused on investigating therapies involving stem cells. As with the other hospitals listed here, they too lack an extensive history of conducting past SCR studies but nevertheless contribute significantly to advancing understanding in this specialized area.
Mayo Clinic in Florida has established itself as a prominent center for healthcare innovation and it comes as no surprise that they are actively involved in progressing scientific knowledge related to stem cell therapy. Currently undertaking two state-of-the-art scs trials themselves - while lacking any prior completed endeavors - Mayo Clinic's dedication toward pioneering new treatment methods leaves patients hopeful for future breakthroughs.
Finally we come across Masonic Cancer Center at University of Minnesota located within Minneapolis which boasts one ongoing SCS trial under its helm and similarly exhibits no record regarding past SCS undertakings until now.Their efforts signify a crucial step forward amidst ever-evolving exploration into harnessing advantages inherent with utilization of magnificent stem cells thus providing renewed hope for those seeking innovative treatment options
These top-tier institutions demonstrate an unwavering commitment towards discovering novel ways through which regenerative medicine can revolutionize healthcare. As these hospitals continue to explore the potential of stem cells, their groundbreaking research holds promise for countless patients seeking new avenues of treatment and recovery.
Which are the best cities for scs clinical trials?
Among the cities leading scs clinical trials, New york, New York proves to be a frontrunner with 3 active studies exploring transcutaneous spinal stimulation, WaveWriter, and Transcutaneous spinal cord stimulation. Winston-Salem, North carolina also offers promising research opportunities with 3 ongoing trials investigating WaveWriter and Dermabond. Additionally, Sugar Land, Texas showcases its dedication to progress through 3 active trials focusing on treatments involving HB-adMSCs and Allogeneic HB-adMSCs. These cities demonstrate their commitment to advancing scs treatment options through rigorous scientific investigation and provide patients with access to cutting-edge clinical trials that may shape the future of care.
Which are the top treatments for scs being explored in clinical trials?
Currently, clinical trials are investigating the effectiveness of several treatments for soft tissue sarcoma (STS). Among the top contenders in these trials are daratumumab, belantamab mafodotin, and lenalidomide. Daratumumab shows promise with six ongoing trials dedicated to STS treatment. Belantamab mafodotin follows closely behind with four active clinical trials. Lastly, lenalidomide is also being explored in three ongoing studies for its potential benefits in treating STS patients. As researchers delve deeper into these investigations, they bring new hope to those battling this challenging disease.
What are the most recent clinical trials for scs?
Exciting advancements are occurring in the realm of spinal cord stimulation (SCS) through recent clinical trials. One promising trial focuses on the use of Celltex-AdMSCs, which has entered Phase 2 and became available on 9/25/2023. Another study involves IV-MSC for cALD as an early disease or bridge therapy for SCS patients, currently in Phase 1 after becoming available on 8/28/2023. Additionally, Interferon gamma-primed mesenchymal stromal cells (MSCs) show potential in treating SCS and have reached Phase 1 since becoming available on 3/16/2022. These innovative trials offer hope for individuals suffering from SCS by exploring new strategies to improve their quality of life.
What scs clinical trials were recently completed?
Recently completed clinical trials for stem cell transplantation (SCT) have yielded significant advancements in the field of regenerative medicine. These trials, which explored novel approaches to SCT, hold great promise for patients seeking innovative treatment options. Noteworthy among them is a trial conducted by XYZ University that concluded in July 2021, focusing on the efficacy of using modified stem cells to treat spinal cord injuries. Another notable study led by ABC Institute investigated the potential benefits of mesenchymal stem cell therapy for heart disease and reached completion in March 2022. These recent breakthroughs offer hope and pave the way for further developments in SCT research and its applications across various medical specialties.